METADATA
last updated: 2026-02-17 RT
file_name: _context-commentary_guides-sds.md
category: guides
subcategory: sds
words: 617
tokens: 844


CONTENT

## Context
The SDS subcategory within the Guides collection contains Safety Data Sheets for the key chemicals used in FloodLAMP's LAMP-based COVID-19 testing workflow, along with an original analysis document addressing waste disposal and risk assessment.

The five SDS files cover the chemicals central to FloodLAMP's reagent system:
- **TCEP** (tris(2-carboxyethyl)phosphine hydrochloride) — the reducing agent used in the Inactivation Saline Solution for viral inactivation; classified as a corrosive solid
- **EDTA** (ethylenediaminetetraacetic acid) — the chelating agent also used in the Inactivation Saline Solution; relatively low hazard at working concentrations
- **Clorox Regular Bleach** (sodium hypochlorite 5–10%) — used for decontamination and cleaning at test sites; corrosive with aquatic toxicity concerns
- **Isopropyl Alcohol 70%** — used for surface disinfection; a Class 3 flammable liquid
- **Twist Synthetic SARS-CoV-2 RNA Control** — the non-hazardous synthetic RNA positive control used in test verification

These SDS files were maintained as a convenient reference for FloodLAMP personnel and pilot site operators, providing standardized hazard, handling, PPE, and disposal information for the chemicals they encountered during testing operations.

The sixth file in the subcategory, "Waste Disposal and Risk Assessment," is an original analysis created during archive preparation. It addresses questions that were operationally important during FloodLAMP's active period: whether the used and unused reagents constituted hazardous waste under federal RCRA and state regulations (California, Florida, and Texas), how pilot sites should have disposed of the two primary waste streams (inactivated sample tubes and spent reaction tubes), and what the regulatory landscape looked like for both the chemical and biological components of the waste. The document also reviews a qualitative biological risk assessment that FloodLAMP commissioned in 2022 and the use-FMEA (uFMEA) document (SOP-004-B) that FloodLAMP began developing to obtain the numerical risk quantification the narrative assessment lacked. These disposal and risk questions connect to the manufacturing subcategory (where the reagent formulations are defined) and to the QMS/SOPs subcategory (where the uFMEA and related SOPs reside).


## Commentary
The substantive commentary for this subcategory lives in the "Waste Disposal and Risk Assessment" file, which documents the analysis I wish we had done more rigorously during FloodLAMP's active period. The core issue was straightforward but consequential: we needed to know whether our reagents and testing waste were hazardous, and how pilot sites in three different states should dispose of them. We had a PhD bioscientist research the question multiple times, and the conclusion — that the working-concentration solutions were not hazardous waste — turns out to be substantially correct from a chemical standpoint. But the full picture is more nuanced than we appreciated at the time, particularly around the concentrated 100X Inactivation Solution (which likely qualifies as D002 corrosive hazardous waste due to NaOH concentration) and the biological waste classification question, which is governed by state medical waste regulations rather than RCRA.

The lesson I take from this is about the value of having AI-assisted research tools for these kinds of regulatory and technical questions. All of that earlier research was done pre-AI, without a written record of the reasoning. During archive preparation, I was able to use AI to produce the detailed, chemical-by-chemical analysis with specific regulatory citations that we should have had on file from the start. For any future decentralized testing operation, I would insist on a documented waste determination memo for each site — something that maps each waste stream to the applicable federal and state regulations and reaches an explicit disposal recommendation. AI tools make this kind of thorough, multi-jurisdictional regulatory research dramatically more accessible, even for a small company without in-house regulatory counsel. That is a genuine advancement for the field: the barrier to getting these operational safety and compliance questions properly answered has dropped significantly.